Relyea Zuckerberg Hanson LLC Sells 42 Shares of Cigna Group $CI

Relyea Zuckerberg Hanson LLC trimmed its holdings in Cigna Group (NYSE:CI) by 3.5% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,165 shares of the health services provider’s stock after selling 42 shares during the quarter. Relyea Zuckerberg Hanson LLC’s holdings in Cigna Group were worth $385,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in CI. Eads & Heald Wealth Management raised its stake in shares of Cigna Group by 3.3% in the second quarter. Eads & Heald Wealth Management now owns 2,469 shares of the health services provider’s stock worth $816,000 after acquiring an additional 78 shares during the last quarter. Chung Wu Investment Group LLC increased its holdings in shares of Cigna Group by 6.6% in the second quarter. Chung Wu Investment Group LLC now owns 1,608 shares of the health services provider’s stock valued at $532,000 after purchasing an additional 100 shares in the last quarter. Valeo Financial Advisors LLC increased its holdings in shares of Cigna Group by 86,071.1% in the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after purchasing an additional 3,471,249 shares in the last quarter. Plimoth Trust Co. LLC raised its position in Cigna Group by 4.8% in the 2nd quarter. Plimoth Trust Co. LLC now owns 4,693 shares of the health services provider’s stock worth $1,551,000 after purchasing an additional 217 shares during the last quarter. Finally, DAVENPORT & Co LLC lifted its holdings in Cigna Group by 2.6% during the 2nd quarter. DAVENPORT & Co LLC now owns 5,924 shares of the health services provider’s stock worth $1,954,000 after buying an additional 150 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on CI shares. Wall Street Zen downgraded Cigna Group from a “buy” rating to a “hold” rating in a research report on Friday. Cantor Fitzgerald reissued an “overweight” rating and set a $365.00 price objective on shares of Cigna Group in a report on Tuesday, August 26th. Deutsche Bank Aktiengesellschaft set a $415.00 price target on shares of Cigna Group and gave the stock a “buy” rating in a research report on Tuesday, August 5th. Barclays increased their price objective on shares of Cigna Group from $354.00 to $383.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. Finally, Wells Fargo & Company reduced their price objective on shares of Cigna Group from $341.00 to $340.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 14th. Two research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, Cigna Group currently has a consensus rating of “Moderate Buy” and an average price target of $371.81.

Insider Buying and Selling at Cigna Group

In other news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider owned 25,648 shares in the company, valued at $7,694,400. The trade was a 52.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.70% of the stock is owned by company insiders.

Cigna Group Stock Down 2.5%

Shares of NYSE CI opened at $303.30 on Tuesday. Cigna Group has a 52-week low of $256.89 and a 52-week high of $358.88. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The stock has a market cap of $80.96 billion, a P/E ratio of 16.56, a P/E/G ratio of 0.91 and a beta of 0.45. The firm has a 50 day moving average price of $292.64 and a 200 day moving average price of $309.56.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company had revenue of $67.13 billion for the quarter, compared to analysts’ expectations of $62.61 billion. During the same period last year, the firm posted $6.72 earnings per share. The business’s quarterly revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were given a dividend of $1.51 per share. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. Cigna Group’s dividend payout ratio (DPR) is currently 32.97%.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.